Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
出版年份 2020 全文链接
标题
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
作者
关键词
-
出版物
Molecular Cancer
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-19
DOI
10.1186/s12943-020-01213-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The novel roles of circRNAs in human cancer
- (2019) Qingfeng Shang et al. Molecular Cancer
- Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
- (2019) Clémence Hollande et al. NATURE IMMUNOLOGY
- The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity
- (2019) J H Jang et al. CARCINOGENESIS
- Circular RNA circTRIM33–12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression
- (2019) Peng-Fei Zhang et al. Molecular Cancer
- Biogenesis, functions and clinical significance of circRNAs in gastric cancer
- (2019) Chan Shan et al. Molecular Cancer
- Circular RNAs (circRNAs) in cancer
- (2018) Ruoyu Zhou et al. CANCER LETTERS
- circRNAs in Cancer
- (2018) Ines Lucia Patop et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma
- (2018) Jian Yu et al. JOURNAL OF HEPATOLOGY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
- (2018) Jian Zhou et al. Liver Cancer
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CircRNAs and cancer: Biomarkers and master regulators
- (2018) Esther Arnaiz et al. SEMINARS IN CANCER BIOLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis
- (2016) Shao-Lai Zhou et al. HEPATOLOGY
- The biogenesis and emerging roles of circular RNAs
- (2016) Ling-Ling Chen NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice
- (2015) Jae-Hwi Jang et al. CLINICAL & EXPERIMENTAL METASTASIS
- Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma
- (2015) Eric I. Marks et al. CURRENT CANCER DRUG TARGETS
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) James P. Allison JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
- (2015) Rosa Barreira da Silva et al. NATURE IMMUNOLOGY
- Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma
- (2015) Heejin Bang et al. Cancer Research and Treatment
- αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma
- (2013) Xiao-Yong Huang et al. HEPATOLOGY
- Natural RNA circles function as efficient microRNA sponges
- (2013) Thomas B. Hansen et al. NATURE
- Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
- (2012) Mary Maluccio et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CD151 Amplifies Signaling by Integrin α6β1 to PI3K and Induces the Epithelial–Mesenchymal Transition in HCC Cells
- (2011) Ai–Wu Ke et al. GASTROENTEROLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma
- (2010) Kazuhiro Tsuji et al. CANCER GENETICS AND CYTOGENETICS
- Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma
- (2008) Ai-Wu Ke et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now